Diane R. Sawicki - Concepedia

Author

Diane R. Sawicki

Institute for Diabetes Discovery

Also Known As

D. R. Sawicki, D.R. Sawicki, DIANE SAWICKI, Diane R Sawicki, Diane R. Sawicki, Diane Sawicki, M. L. Piatti

Publications

990

Citations

H-Index

Concepts

All Affiliations

Institute for Diabetes Discovery Princeton University Centre National de la Recherche Scientifique Women's Health Research Institute Institut de génétique et de biologie moléculaire et cellulaire

About

Diane R. Sawicki is an author at Institute for Diabetes Discovery specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	554
2	Biochemistry	8	8	506
3	Health Sciences	5	5	243
4	Natural Sciences	3	3	284
5	Biomolecular Engineering	2	2	229

Diane R. Sawicki

Publications

897

Citations

H-Index

Page 1

	Year	Citations
Discovery of 3-[(4,5,7-Trifluorobenzothiazol-2-yl)methyl]indole-<i>N</i>-acetic Acid (Lidorestat) and Congeners as Highly Potent and Selective Inhibitors of Aldose Reductase for Treatment of Chronic Diabetic Complications M.C. Van Zandt, Michael L. Jones, David Gunn, Journal of Medicinal Chemistry	2005	222
Novel Benzofuran and Benzothiophene Biphenyls as Inhibitors of Protein Tyrosine Phosphatase 1B with Antihyperglycemic Properties Michael S. Malamas, Janet Sredy, Christopher Moxham, Journal of Medicinal Chemistry Benzofuran/benzothiophene Biphenyl FrameworkChemical BiologyPharmaceutical ChemistryInsulin SignalingEnzyme Active Site	2000	210
PTP1B Inhibition and Antihyperglycemic Activity in the ob/ob Mouse Model of Novel 11-Arylbenzo[<i>b</i>]naphtho[2,3-<i>d</i>]furans and 11-Arylbenzo[<i>b</i>]naphtho[2,3-<i>d</i>]thiophenes Jay Wrobel, Janet Sredy, Christopher Moxham, Journal of Medicinal Chemistry Altmetric Attention ScoreSystem PharmacologyExperimental PharmacologyInsulin SignalingTranslational Pharmacology	1999	126
New Azolidinediones as Inhibitors of Protein Tyrosine Phosphatase 1B with Antihyperglycemic Properties Michael S. Malamas, Janet Sredy, Iwan Gunawan, Journal of Medicinal Chemistry	2000	102
Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat David Walker, Anne L. Carrington, SUSAN A. CANNAN, Journal of Anatomy Early Functional AbnormalitiesPeripheral Nerve InjurySciatic Nerve GlucoseNeuropathic PainPeripheral Nerve	1999	48
Design and synthesis of highly potent and selective (2-arylcarbamoyl-phenoxy)-acetic acid inhibitors of aldose reductase for treatment of chronic diabetic complications M.C. Van Zandt, E. Sibley, Erin E. McCann, Bioorganic & Medicinal Chemistry Medicinal ChemistryDiabetes ManagementAldo-keto ReductaseBiochemistryMedicine	2004	48
Polyol pathway activity in nervous tissues of diabetic and galactose-fed rats: Effect of dietary galactose withdrawal or tolrestat intervention therapy Janet Sredy, Diane R. Sawicki, Ronald R. Notvest Journal of Diabetic Complications Metabolic SyndromeBiochemistryMedicinePhysiologyDiabetes	1991	32
Triglyceride modulation by acifran analogs: activity towards the niacin high and low affinity G protein-coupled receptors HM74A and HM74 Keyvan Mahboubi, Terri Witman-Jones, Jean Adamus, Biochemical and Biophysical Research Communications Molecular PhysiologyLipid SynthesisBiochemistryG Protein-coupled ReceptorAcifran Analogs	2005	27
Discovery of [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acids as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications M.C. Van Zandt, Brian D. Doan, Diane R. Sawicki, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryAldo-keto ReductaseBiochemistryMedicineAldose Reductase	2009	26
Synthesis and PTP1B Inhibition of Novel 4-Aryl-1-Oxa-9-Thiacyclopenta[b]fluorenes Jay Wrobel, Zenan Li, Janet Sredy, Bioorganic & Medicinal Chemistry Letters Ptp1b InhibitionMedicinal ChemistryDrug DiscoveryFluorous SynthesisHeterocycle Chemistry	2000	19

Page 1